Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Dent Disease Treatment Market by Type (Calcium Phosphate, Cysteine, Angiotensin-Converting Enzyme (ACE) Inhibitor, Angiotensin Receptor Blockers, Uric Acid, Calcium Oxalate, Thiazide Diuretics, Others), By Application (Hospitals, Drugs Stores, Retail Pharmacies, Online Pharmacies, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Dent Disease Treatment Market by Type (Calcium Phosphate, Cysteine, Angiotensin-Converting Enzyme (ACE) Inhibitor, Angiotensin Receptor Blockers, Uric Acid, Calcium Oxalate, Thiazide Diuretics, Others), By Application (Hospitals, Drugs Stores, Retail Pharmacies, Online Pharmacies, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 237870 4200 Pharma & Healthcare 377 132 Pages 4.8 (43)
                                          

Market Overview:


The global dent disease treatment market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of dent diseases, rising awareness about dental health, and technological advancements in dent disease treatment methods. Based on type, the global dent disease treatment market is segmented into calcium phosphate, cysteine, angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), uric acid inhibitors, calcium oxalate inhibitors, thiazide diuretics and others. The calcium phosphate segment is expected to dominate the global dent disease treatment market during the forecast period owing to its high efficacy and safety profile.


Global Dent Disease Treatment Industry Outlook


Product Definition:


Dent disease is a rare kidney disorder that primarily affects boys. It is caused by a defect in the gene that helps regulate the amount of phosphate in the blood. This leads to high levels of phosphate in the body, which can damage organs and tissues. Dent disease treatment includes medications to lower phosphate levels and surgery to remove excess fluid from the body.


Calcium Phosphate:


Calcium phosphate is a mineral found in bones, teeth, and blood. It helps maintain the strength of tooth enamel and protects against tooth decay. The most common sources of calcium phosphate are food products such as milk, yogurt, cheese; supplements; and bone meal from animals. Calcium phosphate can also be derived from plants through hydrolysis via plant phosphatase or calciolization.


Cysteine:


Cysteine is an amino acid and its main function in the body is to make proteins. Proteins are important for maintaining the structure of cells, tissues, and organs. The protein content of the human body is constant but there are some variations as per age group; thus, it’s called protean disease or protein fluctuation.


Application Insights:


Based on application, the market is segmented into hospitals, drugs stores, retail pharmacies and online pharmacies. Hospitals held the largest share in 2017 owing to factors such as a large patient base and high prevalence of chronic diseases requiring long-term treatment. Drugs stores are anticipated to be the fastest-growing segment over the forecast period due to increasing awareness about preventive dentistry coupled with rising spending capacity of consumers in developing regions like Asia Pacific and Middle East & Africa.


Retail pharmacies are expected to witness significant growth over the forecast period due to an increase in dental care services among individuals preferring self-treatment at home or seeking professional help from family dentists or oral surgeons for more complex procedures.


Regional Analysis:


North America dominated the global market in 2017. This can be attributed to the presence of a large number of key players, high adoption rate for advanced dent disease treatment methods, and favorable reimbursement policies & regulatory approvals by government agencies. The region is expected to maintain its dominance throughout the forecast period owing to factors such as increasing geriatric population base and rising awareness about oral healthcare among people in this region.


Asia Pacific is anticipated to witness lucrative growth over the forecast period due to factors such as improving economic conditions, growing medical tourism industry, increase in disposable income levels coupled with rise in consumer awareness regarding dental health & hygiene among others. In addition, an increase in new product launches by key players will also drive regional growth during the estimated time span from 2018-2030  (Ref: IMS Health Report 2016).


Growth Factors:


  • Increasing incidence of Dent Disease
  • Growing awareness about Dent Disease Treatment options
  • Rising demand for minimally invasive Dent Disease Treatment procedures
  • Technological advancements in Dent Disease Treatment field
  • increasing number of dentists specializing in Dent Disease Treatment

Scope Of The Report

Report Attributes

Report Details

Report Title

Dent Disease Treatment Market Research Report

By Type

Calcium Phosphate, Cysteine, Angiotensin-Converting Enzyme (ACE) Inhibitor, Angiotensin Receptor Blockers, Uric Acid, Calcium Oxalate, Thiazide Diuretics, Others

By Application

Hospitals, Drugs Stores, Retail Pharmacies, Online Pharmacies, Others

By Companies

Boston Scientific Corporation, Medispec LTD, Elmed Medical Systems Inc, Dornier MedTech, Richard Wolf GmbH, DirexGroup, Cook Medical LLC., Stryker Corporation, Medtronic, Accordion Medical Associates

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

132

Number of Tables & Figures

93

Customization Available

Yes, the report can be customized as per your need.


Global Dent Disease Treatment Market Report Segments:

The global Dent Disease Treatment market is segmented on the basis of:

Types

Calcium Phosphate, Cysteine, Angiotensin-Converting Enzyme (ACE) Inhibitor, Angiotensin Receptor Blockers, Uric Acid, Calcium Oxalate, Thiazide Diuretics, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospitals, Drugs Stores, Retail Pharmacies, Online Pharmacies, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Boston Scientific Corporation
  2. Medispec LTD
  3. Elmed Medical Systems Inc
  4. Dornier MedTech
  5. Richard Wolf GmbH
  6. DirexGroup
  7. Cook Medical LLC.
  8. Stryker Corporation
  9. Medtronic
  10. Accordion Medical Associates

Global Dent Disease Treatment Market Overview


Highlights of The Dent Disease Treatment Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Calcium Phosphate
    2. Cysteine
    3. Angiotensin-Converting Enzyme (ACE) Inhibitor
    4. Angiotensin Receptor Blockers
    5. Uric Acid
    6. Calcium Oxalate
    7. Thiazide Diuretics
    8. Others
  1. By Application:

    1. Hospitals
    2. Drugs Stores
    3. Retail Pharmacies
    4. Online Pharmacies
    5. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Dent Disease Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Dent Disease Treatment Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Dent disease treatment typically includes a combination of oral and dental procedures to restore teeth and gums. Oral surgery may include removal of diseased or damaged teeth, replacement with implants or dentures, restoration of tooth structure using fillers or grafts, and placement of crowns or caps. Dental procedures may include cleaning and restoration of teeth using fluoride treatments, sealants, root canals (to remove decay), extractions (to remove infected tissue), periodontal therapy (to treat gum disease)

Some of the major companies in the dent disease treatment market are Boston Scientific Corporation, Medispec LTD, Elmed Medical Systems Inc, Dornier MedTech, Richard Wolf GmbH, DirexGroup, Cook Medical LLC., Stryker Corporation, Medtronic, Accordion Medical Associates.

The dent disease treatment market is expected to grow at a compound annual growth rate of 5.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Dent Disease Treatment Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Dent Disease Treatment Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Dent Disease Treatment Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Dent Disease Treatment Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Dent Disease Treatment Market Size & Forecast, 2018-2028       4.5.1 Dent Disease Treatment Market Size and Y-o-Y Growth       4.5.2 Dent Disease Treatment Market Absolute $ Opportunity

Chapter 5 Global Dent Disease Treatment Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Dent Disease Treatment Market Size Forecast by Type
      5.2.1 Calcium Phosphate
      5.2.2 Cysteine
      5.2.3 Angiotensin-Converting Enzyme (ACE) Inhibitor
      5.2.4 Angiotensin Receptor Blockers
      5.2.5 Uric Acid
      5.2.6 Calcium Oxalate
      5.2.7 Thiazide Diuretics
      5.2.8 Others
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Dent Disease Treatment Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Dent Disease Treatment Market Size Forecast by Applications
      6.2.1 Hospitals
      6.2.2 Drugs Stores
      6.2.3 Retail Pharmacies
      6.2.4 Online Pharmacies
      6.2.5 Others
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Dent Disease Treatment Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Dent Disease Treatment Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Dent Disease Treatment Analysis and Forecast
   9.1 Introduction
   9.2 North America Dent Disease Treatment Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Dent Disease Treatment Market Size Forecast by Type
      9.6.1 Calcium Phosphate
      9.6.2 Cysteine
      9.6.3 Angiotensin-Converting Enzyme (ACE) Inhibitor
      9.6.4 Angiotensin Receptor Blockers
      9.6.5 Uric Acid
      9.6.6 Calcium Oxalate
      9.6.7 Thiazide Diuretics
      9.6.8 Others
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Dent Disease Treatment Market Size Forecast by Applications
      9.10.1 Hospitals
      9.10.2 Drugs Stores
      9.10.3 Retail Pharmacies
      9.10.4 Online Pharmacies
      9.10.5 Others
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Dent Disease Treatment Analysis and Forecast
   10.1 Introduction
   10.2 Europe Dent Disease Treatment Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Dent Disease Treatment Market Size Forecast by Type
      10.6.1 Calcium Phosphate
      10.6.2 Cysteine
      10.6.3 Angiotensin-Converting Enzyme (ACE) Inhibitor
      10.6.4 Angiotensin Receptor Blockers
      10.6.5 Uric Acid
      10.6.6 Calcium Oxalate
      10.6.7 Thiazide Diuretics
      10.6.8 Others
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Dent Disease Treatment Market Size Forecast by Applications
      10.10.1 Hospitals
      10.10.2 Drugs Stores
      10.10.3 Retail Pharmacies
      10.10.4 Online Pharmacies
      10.10.5 Others
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Dent Disease Treatment Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Dent Disease Treatment Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Dent Disease Treatment Market Size Forecast by Type
      11.6.1 Calcium Phosphate
      11.6.2 Cysteine
      11.6.3 Angiotensin-Converting Enzyme (ACE) Inhibitor
      11.6.4 Angiotensin Receptor Blockers
      11.6.5 Uric Acid
      11.6.6 Calcium Oxalate
      11.6.7 Thiazide Diuretics
      11.6.8 Others
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Dent Disease Treatment Market Size Forecast by Applications
      11.10.1 Hospitals
      11.10.2 Drugs Stores
      11.10.3 Retail Pharmacies
      11.10.4 Online Pharmacies
      11.10.5 Others
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Dent Disease Treatment Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Dent Disease Treatment Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Dent Disease Treatment Market Size Forecast by Type
      12.6.1 Calcium Phosphate
      12.6.2 Cysteine
      12.6.3 Angiotensin-Converting Enzyme (ACE) Inhibitor
      12.6.4 Angiotensin Receptor Blockers
      12.6.5 Uric Acid
      12.6.6 Calcium Oxalate
      12.6.7 Thiazide Diuretics
      12.6.8 Others
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Dent Disease Treatment Market Size Forecast by Applications
      12.10.1 Hospitals
      12.10.2 Drugs Stores
      12.10.3 Retail Pharmacies
      12.10.4 Online Pharmacies
      12.10.5 Others
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Dent Disease Treatment Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Dent Disease Treatment Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Dent Disease Treatment Market Size Forecast by Type
      13.6.1 Calcium Phosphate
      13.6.2 Cysteine
      13.6.3 Angiotensin-Converting Enzyme (ACE) Inhibitor
      13.6.4 Angiotensin Receptor Blockers
      13.6.5 Uric Acid
      13.6.6 Calcium Oxalate
      13.6.7 Thiazide Diuretics
      13.6.8 Others
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Dent Disease Treatment Market Size Forecast by Applications
      13.10.1 Hospitals
      13.10.2 Drugs Stores
      13.10.3 Retail Pharmacies
      13.10.4 Online Pharmacies
      13.10.5 Others
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Dent Disease Treatment Market: Competitive Dashboard
   14.2 Global Dent Disease Treatment Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Boston Scientific Corporation
      14.3.2 Medispec LTD
      14.3.3 Elmed Medical Systems Inc
      14.3.4 Dornier MedTech
      14.3.5 Richard Wolf GmbH
      14.3.6 DirexGroup
      14.3.7 Cook Medical LLC.
      14.3.8 Stryker Corporation
      14.3.9 Medtronic
      14.3.10 Accordion Medical Associates

Our Trusted Clients

Contact Us